Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1642839
PUBLISHER: IMARC | PRODUCT CODE: 1642839
Oral Proteins and Peptides Market Size, Share, Trends, and Forecast by Drug Type, Applications, and Region, 2025-2033
PUBLISHED:
PAGES: 138 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global oral proteins and peptides market size was valued at USD 1.8 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 3.4 Billion by 2033, exhibiting a CAGR of 7.13% from 2025-2033. North America currently dominates the market, holding a market share of over 97.8% in 2024. The market is growing due to advancements in drug delivery technologies and the rising demand for non-invasive treatments. Key drivers include the increasing prevalence of chronic diseases like diabetes and cancer coupled with ongoing collaborations between biotech firms and research institutions fostering innovation.
Proteins and peptides are natural components of the human body and play essential roles in many biological processes. Due to their complex structure and susceptibility to digestion in the stomach and small intestine, they are usually administered through injections. However, oral proteins and peptides can be taken via the oral path to treat hormonal, gastric, and metabolic disorders. They are designed to overcome these challenges by using specialized formulations that protect the molecules from digestion and allow them to be absorbed through the intestinal wall into the bloodstream. These formulations include enteric coatings, nanoparticles, and other delivery technologies. Oral proteins and peptides are extensively utilized to treat numerous chronic diseases, such as diabetes, cancer, and autoimmune disorders.
Oral Proteins and Peptides Market Trends:
The increasing volume of patients suffering from chronic diseases, such as cancer, diabetes, cardiovascular disorders (CVDs), and acquired immunodeficiency syndrome (AIDs), and the expanding geriatric population represent the key factors driving the oral proteins and peptides market growth. Besides this, shifting preferences and the rising demand for effective oral drugs and technology among the masses are contributing to the market growth. Moreover, the escalating consumer health consciousness and the growing awareness of the numerous benefits associated with the consumption of oral protein and peptide supplements are creating a positive outlook for the market. In addition to this, innovative technological advancements, such as three-dimensional (3D) printing, nanotechnology, and genetic engineering, have enabled manufacturers to produce more advanced and cost-effective product variants, which is acting as another significant growth-inducing factor. Concurrent with this, the extensive collaborative efforts between pharmaceutical companies, significant advancements in the healthcare infrastructure, and rising research and development (R&D) activities are presenting remunerative growth opportunities for the market. Furthermore, the inflating disposable income of consumers, the widespread adoption of protein-rich diets, the surging demand for protein powder, bars, and shakes, and the increasing proliferation of online platforms providing easy product access are aiding in market expansion.
Oral Proteins and Peptides Industry Segmentation:
Drug Type Insights:
- Linaclotide
- Plecanatide
- Calcitonin
- Insulin
- Octreotide
Application Insights:
- Gastric and Digestive Disorders
- Bone Diseases
- Diabetes
- Hormonal Disorders
Regional Insights:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
- The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for oral proteins and peptides. Some of the factors driving the North America oral proteins and peptides market included the increasing prevalence of chronic diseases, the shifting consumer preference for oral drugs, and innovative product advancements.
Competitive Landscape:
- The report has also provided a comprehensive analysis of the competitive landscape in the global oral proteins and peptides market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Amryt Pharma Plc, AstraZeneca PLC, Biocon Limited, Novo Nordisk A/S, Oramed Ltd, Proxima Concepts Limited, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
- 1.How big is the oral proteins and peptides market?
- 2.What is the future outlook of oral proteins and peptides market?
- 3.What are the key factors driving the oral proteins and peptides market?
- 4.Which region accounts for the largest oral proteins and peptides market share?
- 5.Which are the leading companies in the global oral proteins and peptides market?
Product Code: SR112025A7530
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Oral Proteins and Peptides Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Drug Type
- 6.1 Linaclotide
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Plecanatide
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Calcitonin
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Insulin
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Octreotide
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
7 Market Breakup by Application
- 7.1 Gastric and Digestive Disorders
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Bone Diseases
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Diabetes
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Hormonal Disorders
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Region
- 8.1 North America
- 8.1.1 United States
- 8.1.1.1 Market Trends
- 8.1.1.2 Market Forecast
- 8.1.2 Canada
- 8.1.2.1 Market Trends
- 8.1.2.2 Market Forecast
- 8.1.1 United States
- 8.2 Asia-Pacific
- 8.2.1 China
- 8.2.1.1 Market Trends
- 8.2.1.2 Market Forecast
- 8.2.2 Japan
- 8.2.2.1 Market Trends
- 8.2.2.2 Market Forecast
- 8.2.3 India
- 8.2.3.1 Market Trends
- 8.2.3.2 Market Forecast
- 8.2.4 South Korea
- 8.2.4.1 Market Trends
- 8.2.4.2 Market Forecast
- 8.2.5 Australia
- 8.2.5.1 Market Trends
- 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
- 8.2.6.1 Market Trends
- 8.2.6.2 Market Forecast
- 8.2.7 Others
- 8.2.7.1 Market Trends
- 8.2.7.2 Market Forecast
- 8.2.1 China
- 8.3 Europe
- 8.3.1 Germany
- 8.3.1.1 Market Trends
- 8.3.1.2 Market Forecast
- 8.3.2 France
- 8.3.2.1 Market Trends
- 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
- 8.3.3.1 Market Trends
- 8.3.3.2 Market Forecast
- 8.3.4 Italy
- 8.3.4.1 Market Trends
- 8.3.4.2 Market Forecast
- 8.3.5 Spain
- 8.3.5.1 Market Trends
- 8.3.5.2 Market Forecast
- 8.3.6 Russia
- 8.3.6.1 Market Trends
- 8.3.6.2 Market Forecast
- 8.3.7 Others
- 8.3.7.1 Market Trends
- 8.3.7.2 Market Forecast
- 8.3.1 Germany
- 8.4 Latin America
- 8.4.1 Brazil
- 8.4.1.1 Market Trends
- 8.4.1.2 Market Forecast
- 8.4.2 Mexico
- 8.4.2.1 Market Trends
- 8.4.2.2 Market Forecast
- 8.4.3 Others
- 8.4.3.1 Market Trends
- 8.4.3.2 Market Forecast
- 8.4.1 Brazil
- 8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast
9 Drivers, Restraints, and Opportunities
- 9.1 Overview
- 9.2 Drivers
- 9.3 Restraints
- 9.4 Opportunities
10 Value Chain Analysis
11 Porters Five Forces Analysis
- 11.1 Overview
- 11.2 Bargaining Power of Buyers
- 11.3 Bargaining Power of Suppliers
- 11.4 Degree of Competition
- 11.5 Threat of New Entrants
- 11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
- 13.1 Market Structure
- 13.2 Key Players
- 13.3 Profiles of Key Players
- 13.3.1 Amryt Pharma Plc
- 13.3.1.1 Company Overview
- 13.3.1.2 Product Portfolio
- 13.3.2 AstraZeneca PLC
- 13.3.2.1 Company Overview
- 13.3.2.2 Product Portfolio
- 13.3.2.3 Financials
- 13.3.2.4 SWOT Analysis
- 13.3.3 Biocon Limited
- 13.3.3.1 Company Overview
- 13.3.3.2 Product Portfolio
- 13.3.3.3 Financials
- 13.3.3.4 SWOT Analysis
- 13.3.4 Novo Nordisk A/S
- 13.3.4.1 Company Overview
- 13.3.4.2 Product Portfolio
- 13.3.4.3 Financials
- 13.3.4.4 SWOT Analysis
- 13.3.5 Oramed Ltd
- 13.3.5.1 Company Overview
- 13.3.5.2 Product Portfolio
- 13.3.5.3 Financials
- 13.3.6 Proxima Concepts Limited
- 13.3.6.1 Company Overview
- 13.3.6.2 Product Portfolio
- 13.3.1 Amryt Pharma Plc
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Product Code: SR112025A7530
List of Figures
- Figure 1: Global: Oral Proteins and Peptides Market: Major Drivers and Challenges
- Figure 2: Global: Oral Proteins and Peptides Market: Sales Value (in Billion USD), 2019-2024
- Figure 3: Global: Oral Proteins and Peptides Market Forecast: Sales Value (in Billion USD), 2025-2033
- Figure 4: Global: Oral Proteins and Peptides Market: Breakup by Drug Type (in %), 2024
- Figure 5: Global: Oral Proteins and Peptides Market: Breakup by Application (in %), 2024
- Figure 6: Global: Oral Proteins and Peptides Market: Breakup by Region (in %), 2024
- Figure 7: Global: Oral Proteins and Peptides (Linaclotide) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 8: Global: Oral Proteins and Peptides (Linaclotide) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 9: Global: Oral Proteins and Peptides (Plecanatide) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 10: Global: Oral Proteins and Peptides (Plecanatide) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 11: Global: Oral Proteins and Peptides (Calcitonin) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 12: Global: Oral Proteins and Peptides (Calcitonin) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 13: Global: Oral Proteins and Peptides (Insulin) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 14: Global: Oral Proteins and Peptides (Insulin) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 15: Global: Oral Proteins and Peptides (Octreotide) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 16: Global: Oral Proteins and Peptides (Octreotide) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 17: Global: Oral Proteins and Peptides (Gastric and Digestive Disorders) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 18: Global: Oral Proteins and Peptides (Gastric and Digestive Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 19: Global: Oral Proteins and Peptides (Bone Diseases) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 20: Global: Oral Proteins and Peptides (Bone Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 21: Global: Oral Proteins and Peptides (Diabetes) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 22: Global: Oral Proteins and Peptides (Diabetes) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 23: Global: Oral Proteins and Peptides (Hormonal Disorders) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 24: Global: Oral Proteins and Peptides (Hormonal Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 25: North America: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
- Figure 26: North America: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 27: United States: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
- Figure 28: United States: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 29: Canada: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
- Figure 30: Canada: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 31: Asia-Pacific: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
- Figure 32: Asia-Pacific: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 33: China: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
- Figure 34: China: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 35: Japan: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
- Figure 36: Japan: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 37: India: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
- Figure 38: India: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 39: South Korea: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
- Figure 40: South Korea: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 41: Australia: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
- Figure 42: Australia: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 43: Indonesia: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
- Figure 44: Indonesia: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 45: Others: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
- Figure 46: Others: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 47: Europe: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
- Figure 48: Europe: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 49: Germany: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
- Figure 50: Germany: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 51: France: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
- Figure 52: France: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 53: United Kingdom: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
- Figure 54: United Kingdom: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 55: Italy: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
- Figure 56: Italy: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 57: Spain: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
- Figure 58: Spain: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 59: Russia: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
- Figure 60: Russia: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 61: Others: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
- Figure 62: Others: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 63: Latin America: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
- Figure 64: Latin America: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 65: Brazil: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
- Figure 66: Brazil: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 67: Mexico: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
- Figure 68: Mexico: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 69: Others: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
- Figure 70: Others: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 71: Middle East and Africa: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
- Figure 72: Middle East and Africa: Oral Proteins and Peptides Market: Breakup by Country (in %), 2024
- Figure 73: Middle East and Africa: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 74: Global: Oral Proteins and Peptides Industry: Drivers, Restraints, and Opportunities
- Figure 75: Global: Oral Proteins and Peptides Industry: Value Chain Analysis
- Figure 76: Global: Oral Proteins and Peptides Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Oral Proteins and Peptides Market: Key Industry Highlights, 2024 & 2033
- Table 2: Global: Oral Proteins and Peptides Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
- Table 3: Global: Oral Proteins and Peptides Market Forecast: Breakup by Application (in Million USD), 2025-2033
- Table 4: Global: Oral Proteins and Peptides Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 5: Global: Oral Proteins and Peptides Market: Competitive Structure
- Table 6: Global: Oral Proteins and Peptides Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.